US Stocks
/
Boundless Bio, Inc. Share Price

Boundless Bio, Inc. Share Price

NASDAQ: BOLD | Micro Cap
$2.58
-$0.06 (-2.46%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Boundless Bio, Inc. Stock Performance

Open
$2.63
Prev. Close
$2.64
Circuit Range
N/A
Day Range
$2.51 - $2.64
Year Range
$0.98 - $3.12
Volume
4,648
Average Traded
$2.56

Boundless Bio, Inc. Share Price Today

As of 9 October 2026, Boundless Bio, Inc.'s share price is $2.58. The stock opened at $2.63, compared to its previous close of $2.64. During today's trading session, Boundless Bio, Inc.'s share price traded between $2.51 and $2.64, with an average price of $2.58. Over the past 52 weeks, the stock has recorded a high of $3.12 and a low of $0.98. In terms of performance, Boundless Bio, Inc.'s share price has risen by 76.98% over the last six months and is up 87.96% on a year-on-year basis.

Boundless Bio, Inc. Share Price Chart

$2.51$2.64
L
Show Current Price
H

Boundless Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$57.58M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.81
Revenue (TTM)
$0.00
Return On Equity (TTM)
-97.02%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-70.68%

Boundless Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.88-$12.89-$13.56-$23.69
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A7.13%-5.20%-74.71%

Boundless Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$65.36-$58.20
Net Profit MarginN/AN/A
Income ChangeN/A10.95%

About Boundless Bio, Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Boundless Bio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.59
$2.63
+6.26%
Sep 2026
$2.81
$2.48
-14.06%
Aug 2026
$2.51
$2.88
+15.66%
Jul 2026
$2.50
$2.49
-0.60%
Jun 2026
$1.46
$2.50
+71.58%
May 2026
$1.51
$1.46
+0.34%
Apr 2026
$1.14
$1.46
+31.08%
Mar 2026
$1.13
$1.11
-4.31%
Feb 2026
$1.14
$1.16
+0.87%
Jan 2026
$1.22
$1.15
-3.36%
Dec 2025
$1.17
$1.19
+3.03%
Nov 2025
$1.28
$1.16
-15.69%

BOLD Share Price FAQs

What is Boundless Bio, Inc. share price today?

chevron-up
Boundless Bio, Inc. share price today is $2.58 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Boundless Bio, Inc. stock?

chevron-up
The 52 week high of Boundless Bio, Inc. stock is $3.12, while the 52 week low is $0.98 as of 9 Oct '26.

What is BOLD's market capitalisation today?

chevron-up
BOLD market capitalisation is $57.58M as of October 9, 2026, at 4:45 pm IST.

What is BOLD's net income for the last quarter?

chevron-up
BOLD's net income for the last quarter is -23.69B USD.

What is the 5 year returns of BOLD?

chevron-up
The 5 year returns of BOLD is -95.71% as on 9 Oct '26.

What is the high & low stock price of BOLD today?

chevron-up
BOLD stock price hit a high of $2.64 and low of $2.51 as of 9 Oct '26.

Can I buy BOLD shares in India?

chevron-up
Yes. You can buy BOLD in India by opening an international trading account.